Evidence map›Paper›PMID 20810168›Full record

Trial reportEvaluation and program planning2011

Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States.

David R Lairson, Wen Chan, Yu-Chia Chang, Deborah J del Junco, Sally W Vernon

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Evaluation and program planning, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David R LairsonUniversity of Texas Health Science Center at Houston, School of Public Health, 1200 Pressler Drive, Houston, TX 77030, United States. david.r.lairson@uth.tmc.edu
Wen Chan
Yu-Chia Chang
Deborah J del Junco
Sally W Vernon
The University of Texas Health Science Center at Houston · US

Funding

WOMEN VETERANS AND BREAST CANCER SCREENINGR01CA076330 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI VERNON, SALLY W · 1999 to 2003
$2.3M
NCI NIH HHS 1R01 CA 76330-01A2NCI NIH HHS R01 CA076330
6 · The paper itself

Abstract

objectiveWe conducted an economic evaluation of mammography promotion interventions in a population-based, nationally representative sample of 5500 women veterans.

methodsWomen 52 years and older were randomly selected from the National Registry of Women Veterans and randomly assigned to a survey-only control group and two intervention groups that varied in the extent of personalization (tailored vs. targeted). Effectiveness measures were the prevalence of at least one self-reported post-intervention mammogram and two post-intervention mammograms 6-15 months apart. Incremental cost-effectiveness ratios (ICERs) were the incremental cost per additional person screened. Uncertainty was examined with sensitivity analysis and bootstrap simulation.

resultsThe targeted intervention cost $25 per person compared to $52 per person for the tailored intervention. About 27% of the cost was incurred in identifying and recruiting the eligible population. The percent of women reporting at least one mammogram were .447 in the control group, .469 in the targeted group, and .460 in the tailored group. The ICER was $1116 comparing the targeted group to the control group (95% confidence interval (CI)=$493 to dominated). The tailored intervention was dominated (more costly and less effective) by the targeted intervention.

conclusionDecision-makers should consider effectiveness evidence and the full recruitment and patient time costs associated with the implementation of screening interventions when making investments in mammography screening promotion programs. Identification and recruitment of eligible participants add substantial costs to outreach screening promotion interventions. Tailoring adds substantial cost to the targeted mammography promotion strategy without a commensurate increase in effectiveness. Although cost-effectiveness has been reported to be higher for some in-reach screening promotion interventions, a recent meta-analysis revealed significant heterogeneity in the effect sizes of published health-plan based intervention studies for repeat mammography (i.e., some studies reported null effects compared with control groups).

Indexed as

Breast NeoplasmsCost-Benefit AnalysisEarly Detection of CancerFemaleHumansMammographyMarketing of Health ServicesMiddle AgedModels, EconomicPrevalenceUnited StatesVeterans

Identifiers

PMID20810168
PMCPMC3039699
OpenAlexW2055008582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.